PRNewsWire
07 Jun 2026, 22:30 UTC · 14h ago
VolitionRx Announces Pricing of $4.6 Million Public Offering
PRNewsWire
07 Jun 2026, 22:30 UTC · 14h ago
Story key points
3 claims · impact-rated
VolitionRx is pricing a public offering of 2,960,000 shares of common stock and warrants at $1.55 per share and half-warrant. — Public offerings typically cause immediate share price dilution for existing stockholders.
-0.40The company expects to raise approximately $4.6 million in upfront gross proceeds from the offering. — Increased cash runway is a positive for a clinical-stage company's operational stability.
+0.20The offering includes warrants to purchase up to 1,480,000 additional shares, potentially providing another $2.3 million in gross proceeds. — Warrants create potential future dilution, though they provide a secondary path for capital raising.
-0.10Ticker attribution
Model heads
Continue reading
6 related stories
Top 2 movers · tap to explore
The company is issuing a public offering of common stock and warrants, which typically leads to share dilution for existing investors.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Barrons
3h ago
